¡Ê¢¨¼Ì¿¿¤Ï¥¤¥á¡¼¥¸¤Ç¤¹¡¿PIXTA¡Ë

¼Ì¿¿³ÈÂç

¤¢¤ëÆüÆÍÁ³¡¢Â­¤Î¿Æ»Ø¤Ë·ãÄˤò°ú¤­µ¯¤³¤¹¡ÖÄËÉ÷¡×¡£·ò¿Ç¤Ê¤É¤ÇÇ¢»ÀÃͤ¬¹â¤¤¤È»ØŦ¤µ¤ì¤¿¡ÖÄËÉ÷ͽÈ÷·³¡×¤Î¿Í¤â¾¯¤Ê¤¯¤Ê¤¤¤Ç¤·¤ç¤¦¡£ÄËÉ÷Âкö¤È¤¤¤¨¤Ð¡Ö¥×¥ê¥óÂÎÀ©¸Â¡×¤¬Í­Ì¾¤Ç¤¹¤¬¡¢¤É¤ì¤Û¤É¤Î¸ú²Ì¤¬¤¢¤ë¤Î¤Ç¤·¤ç¤¦¤«¡©¡¡Ëܵ­»ö¤Ç¤ÏÊƹñϷǯ°å³Ø¤ÎÀìÌç°å¤Ç¤¢¤ë»³ÅÄͪ»Ë»á¤Ë¤è¤ëÃø½ñ¡Ø·ò¹¯¤ÎÂ絿Ìä¡Ù¡Ê¥Þ¥¬¥¸¥ó¥Ï¥¦¥¹¡Ë¤«¤é°ìÉôÈ´¿è¤·¤Æ¡¢¥×¥ê¥óÂÎÀ©¸Â¤Î¸ú²Ì¤ä¤â¤Ã¤ÈÍ¥À褹¤Ù¤­Âкö¤Ë¤Ä¤¤¤Æ²òÀ⤷¤Þ¤¹¡£

¡ÖÄËÉ÷¤Ë¥×¥ê¥óÂÎÀ©¸Â¤¬Í­¸ú¡×¤ÏËÜÅö¡©

¡Ö¤³¤ÎÁ°°å¼Ô¤ËÄËÉ÷¤À¤Ã¤Æ¸À¤ï¤ì¤Æ¡¢¥×¥ê¥óÂΤò¹µ¤¨¤Ê¤¤¤È¤¤¤±¤Ê¤¤¤ó¤À¤è¡×

¡ÖÄËÉ÷¤Ë¤Ê¤é¤Ê¤¤¤è¤¦¤Ë¡¢¥×¥ê¥óÂΤξ¯¤Ê¤¤¥Ó¡¼¥ë¤Ë¤·¤Æ¤¤¤ë¡×

¤½¤ó¤Ê¥»¥ê¥Õ¤òʹ¤¤¤¿¤³¤È¤Ï¤¢¤ë¤Ç¤·¤ç¤¦¤«¡£¡ÖÄËÉ÷¤Ê¤é¥×¥ê¥óÂÎÀ©¸Â¡×¤È¤¤¤¦¤Î¤ÏȾ¤Ð¾ï¼±¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤³¤È¤«¤â¤·¤ì¤Þ¤»¤ó¡£¤³¤Î¡Ö¾ï¼±¡×¤Ï¡¢²Ê³ØŪ¤Êº¬µò¤Ë´ð¤Å¤¯¤â¤Î¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡£¤½¤Î¿¿Áê¤ËÇ÷¤ëÁ°¤Ë¡¢ÄËÉ÷¤Î¸¶°ø¤È¤Ê¤ëÇ¢»À¤ä¥×¥ê¥óÂΤˤĤ¤¤Æ¡¢¾¯¤·¤Ò¤â¤È¤¤¤Æ¤ß¤¿¤¤¤È»×¤¤¤Þ¤¹¡£

¥×¥ê¥óÂΤϡ¢Ç¢»À¤Î¡Ö¸¶ÎÁ¡×¤Ê¤Î¤Ç¤¹¤¬¡¢¤³¤Î¥×¥ê¥óÂΤ¬¤É¤³¤«¤éÍè¤ë¤Î¤«¤È¤¤¤¨¤Ð¡¢¼Â¤Ï¾¯¤Ê¤¯¤È¤â6³ä¤Û¤É¤Ï¼«Ê¬¤ÎÂΤÎÃ椫¤é¤Ç¤¹1¡£¿Í´Ö¤ÎÂΤòÀ®¤¹°ì¤Ä¤Ò¤È¤Ä¤ÎºÙ˦¤ÎÃæ¤Ë¤Ï¡¢³Ë¤È¸Æ¤Ð¤ì¤ëÃù¢¸Ë¤¬¤¢¤ê¡¢¤½¤³¤ËDNA¤È¸Æ¤Ð¤ì¤ë°äÅÁ»Ò¾ðÊó¤òºÜ¤»¤¿½ñʪ¤Î¤è¤¦¤Ê¤â¤Î¤¬¼ýǼ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

°ì¤Ä¤Ò¤È¤Ä¤ÎºÙ˦¤âÍÍ¡¹¤Ê¤â¤Î¤ò¾ÃÈñ¤·Â³¤±¡¢¤¢¤ë¤¤¤ÏÂΤÎÃæ¤ÇÀ¸»à¤â·«¤êÊÖ¤·¤Æ¤ª¤ê¡¢¤ä¤¬¤Æ¤Ï¤´¤ß¤¬½Ð¤µ¤ì¤Æ¤¤¤­¤Þ¤¹¡£¤³¤Î³Ë¤«¤é½Ð¤¿¤´¤ß¤¬¥×¥ê¥óÂΤȸƤФ졢¤³¤ì¤¬½èÍý¤µ¤ì¤Æ¡¢¤ä¤¬¤ÆÇ¢»À¤È¤Ê¤ê¤Þ¤¹¡£Ç¢»À¤Ï¡¢·ì±ÕÃæ¤ËÍϤ±½Ð¤·¡¢¤½¤ì¤¬Ç¢Ãæ¡Ê¤¢¤ë¤¤¤ÏÊØÃæ¡Ë¤ËÇÓÝõ¤µ¤ì¤Þ¤¹¡£¤³¤¦¤·¤Æ¤´¤ß½èÍý¤Ï´°Î»¤Ç¤¹¡£

¤Ç¤Ï¡¢»Ä¤ê¤ÎÇ¢»À¤Ï¤É¤³¤«¤éÍè¤ë¤«¤È¤¤¤¨¤Ð¿©Êª¤Ë¤Ê¤ê¤Þ¤¹¡£µí¤äÆÚ¤ò¿©¤Ù¤¿¤È¤·¤Æ¤â¡¢ÅöÁ³¤½¤ÎÆÚ¤äµí¤âºÙ˦¤«¤é¹½À®¤µ¤ì¤Æ¤¤¤ë¤ï¤±¤Ç¡¢¤½¤³¤Ë¤Ï¥×¥ê¥óÂΤ¬¤¢¤ê¡¢¤½¤·¤ÆÇ¢»À¤Î¸»¤Ë¤Ê¤ë¤È¤¤¤¦¤ï¤±¤Ç¤¹¡£¤³¤ì¤é¤Î¡Ö¤´¤ß½èÍý¡×¤ò¤ä¤Ã¤Æ¤¤¤ë¾ì½ê¤Ï´Î¡¤Ç¤¹¡£

¤´¤ß½èÍý¤¬¤´¤ß¤ÎÎÌÁê±þ¤Ë¹Ô¤ï¤ì¤ì¤ÐÌäÂê¤Ï¤Ê¤¤¤Î¤Ç¤¹¤¬¡¢Ç¢»À¤Îºî¤é¤ì¤ëÎ̤¬¼Î¤Æ¤ëÎ̤ò¾å²ó¤ë¤È¡¢¤ä¤¬¤ÆÇ¢»À¤ÎÃͤ¬¹â¤¯¤Ê¤ê¡¢¤½¤ì¤¬´ØÀá¤ËÃßÀѤ¹¤ì¤ÐÄËÉ÷¤È¸Æ¤Ð¤ì¤ë´ØÀá¤Î±ê¾É¤ò°ú¤­µ¯¤³¤¹¸¶°ø¤Ë¤Ê¤ê¤Þ¤¹¡£¤¢¤ë¤¤¤Ï¡¢Ç¢¤Ë¤¿¤¯¤µ¤óÇ¢»À¤ò¼Î¤Æ¤ë¾õ¶·¤Ë¤Ê¤ë¤È¡¢Ç¢»À¤¬Ç¢¤ÎÃæ¤Ç·ë¾½²½¤·¤Æ¤·¤Þ¤¦¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£¤¹¤ë¤È¡¢Ç¢¤ÎÄ̤êÆ»¤ËµÍ¤Þ¤ê¤òµ¯¤³¤·¤Æ¤·¤Þ¤¦²ÄǽÀ­¤¬¤¢¤ê¡¢¤³¤ì¤ò¡ÖǢϩ·ëÀоɡפȸƤó¤Ç¤¤¤Þ¤¹¡£

Ä»¤Ï¡¢Ç¢»À¤òʬ²ò¤¹¤ë¡Ö¹ÚÁǡפȤ¤¤¦¤â¤Î¤ò»ý¤Ã¤Æ¤¤¤Æ¡¢Ç¢»À¤¬Áý¤¨¤Æ¤âʬ²ò¤Ç¤­¤ë¤Î¤ÇÄËÉ÷¤Ç¶ì¤·¤à¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£³Î¤«¤Ë¡¢´ØÀá¤òÄˤ¬¤Ã¤Æ¤¤¤ëÄ»¤Ë½Ð²ñ¤Ã¤¿¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¤è¤Í¡Ê²¾¤ËÄˤ¬¤Ã¤Æ¤¤¤Æ¤âʬ¤«¤é¤Ê¤¤¤«¤â¤·¤ì¤Þ¤»¤ó¤¬¡Ë¡£¤È¤³¤í¤¬¡¢¿Í´Ö¤Ï¤½¤ì¤òʬ²ò¤¹¤ë¤¿¤á¤Î¹ÚÁǤò»ý¤Ã¤Æ¤¤¤Ê¤¤¤Î¤Ç¡¢¼Î¤Æ³¤±¤Ê¤±¤ì¤ÐÇ¢»À¤Ïί¤Þ¤Ã¤Æ¤·¤Þ¤¤¤Þ¤¹¡£

ÄËÉ÷¤Ê¤É¤Îɵ¤¤òȯ¾É¤·¤¿ºÝ¤Ë¤Ï¡¢Ç¢»ÀÃͤò¹â¤¤¤Þ¤Þ¤Ë¤·¤Æ¤ª¤¯¤È¡¢·«¤êÊÖ¤·Æ±ÍͤÎÉÂÂÖ¤òȯ¾É¤·¤Æ¤·¤Þ¤¦¤¿¤á¡¢Ç¢»À¤ò²¼¤²¤ë¼£ÎŤò¤·¤Þ¤¹¡£¤³¤ì¤Ï¡¢°û¤ßÌô¤Ë¤è¤ë¼£ÎŤ¬´ðËܤˤʤê¤Þ¤¹¡£

¤³¤ì¤Ë²Ã¤¨¤Æ¡¢Àè¤Û¤É¤´ÀâÌÀ¤·¤¿¤è¤¦¤Ë¡¢¥×¥ê¥óÂΤϡ¢ÂÎÆâ¤Çºî¤é¤ì¤ë¤â¤Î°Ê³°¤Ë¡¢¿©»ö¤«¤é¤ÎÀݼè¤Ë¤è¤ëÉôʬ¤â¤¢¤ë¤¿¤á¡¢¥×¥ê¥óÂΤ¬Â¿¤¯´Þ¤Þ¤ì¤ë¿©ÉʤÏÀ©¸Â¤µ¤ì¤ë¤Ù¤­¤À¤È¤¤¤¦¤Î¤¬Ä¹Ç¯¤Î¾ï¼±¤È¤·¤ÆÃΤé¤ì¤Æ¤­¤Þ¤·¤¿¡£

¥×¥ê¥óÂÎÀ©¸Â¤è¤ê¤âÍ¥À褹¤Ù¤­¡ÖÄËÉ÷Âкö¡×¤È¤Ï

¤·¤«¤·¡¢¼ÂºÝ¤Ë¤Ï¡¢¿©ÉʤòÄ´À°¤·¤Æ¤â¤¿¤é¤µ¤ì¤ë±Æ¶Á¤Ï¡Ê¥¼¥í¤Ç¤Ï¤Ê¤¤¤â¤Î¤Î¡ËÂ礭¤¯¤Ê¤¤¤È¤¤¤¦¤³¤È¤¬Ê£¿ô¤Î¸¦µæ¤«¤éʬ¤«¤Ã¤Æ¤­¤Æ¤¤¤Þ¤¹¡£

³Î¤«¤Ë¡¢Â¿¤¯¤Î¿©ÎÁ¤ËÄøÅ٤κ¹¤³¤½¤¢¤ì¥×¥ê¥óÂΤ¬´Þ¤Þ¤ì¤Æ¤¤¤ë¤ï¤±¤Ç¤¹¤·¡¢Ìó6³ä¤ÏÂΤǾ¡¼ê¤ËÀ¸¤ß½Ð¤µ¤ì¤ë¤â¤Î¤Ç¤¹¡£¿©»ö¤Ë¤è¤ëº¹Ê¬¤¬¤¢¤Þ¤êÂ礭¤¯¤Ê¤µ¤½¤¦¤À¤È¤¤¤¦¤³¤È¤ÏÁÛÁü¤ËÆñ¤·¤¯¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¡£

¤³¤Î¤¿¤á¡¢ÉáÄ̤ο©À¸³è¤òÁ÷¤Ã¤Æ¤¤¤ë¿Í¤¬¥×¥ê¥óÂÎÀ©¸Â¤ò¤·¤Æ¤â¡¢¤Û¤È¤ó¤É̵¸ú¤Ç¤¢¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹2¡£¼ÂºÝ¤Ë¡¢¥×¥ê¥óÂÎÀ©¸Â¤Ë¤è¤Ã¤ÆÊ¿¶Ñ¤ÇÇ¢»ÀÃͤÏ1­Ó¡¿dL¤·¤«²¼¤¬¤é¤Ê¤¤¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤¹¡£

¤Þ¤¿¡¢²áÅ٤Υץê¥óÂÎÀ©¸Â¤Ï¡¢·ë²Ì¤È¤·¤Æ¥¿¥ó¥Ñ¥¯¼ÁÀ©¸Â¤Ë¤Ä¤Ê¤¬¤ê¡¢¿©»öÎ̤ËÊѲ½¤¬¤Ê¤¤¾ì¹ç¡¢¤«¤ï¤ê¤Ëú¿å²½Êª¤ä»é¼Á¤ÎÀݼèÎ̤¬Áý¤¨¤Æ¡¢¥Ð¥é¥ó¥¹¤òÊø¤·¤¿¿©À¸³è¤ò¤â¤¿¤é¤¹¤³¤È¤Ë¤Ê¤ê¡¢·ò¹¯¤Ø¤Î°­±Æ¶Á¤¬·üÇ°¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

¤³¤Î¤¿¤á¡¢¥×¥ê¥óÂÎÀ©¸Â¤Ï¡¢¶Ëü¤Ë¥×¥ê¥óÂΤÎÀݼèÎ̤¬Â¿¤¤¾ì¹ç°Ê³°¤Ï¡¢¿ä¾©¤µ¤ì¤ë¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£¤â¤Á¤í¤ó¡¢¶Ëü¤ËÀݼèÎ̤¬Â¿¤¤¾ì¹ç¤Ë¤Ï¡¢ÄËÉ÷¤Î¸¶°ø¤Î°ìü¤òô¤¦¤È¹Í¤¨¤é¤ì¤Þ¤¹¤·¡¢À©¸Â¤¹¤ë°ÕÌ£¤Ï¤¢¤ë¤Ç¤·¤ç¤¦3¡£

ÄËÉ÷¤òËɤ°¤¿¤á¤ËɬÍפʤ³¤È¤Ï¡¢¤à¤·¤í¡¢ÈîËþ¤Î¤¢¤ëÊý¤Î¥À¥¤¥¨¥Ã¥È¡¢°û¼ò¤ò¤¹¤ëÊý¤ÎÀá¼ò¡¢¤½¤·¤Æ¥Ð¥é¥ó¥¹¤ÎÎɤ¤¿©À¸³è¤Ç¤¹2¡£

¡Ö¥Ó¡¼¥ë¤Ï¥×¥ê¥óÂΥե꡼¤Î¥Ó¡¼¥ë¤ËÊѤ¨¤ì¤Ð¤¤¤¯¤é°û¤ó¤Ç¤âÎɤ¤¡×¤Ê¤ó¤Æ¤¤¤¦Ïäòʹ¤¯¤³¤È¤â¤¢¤ê¤Þ¤¹¤¬¡¢¤½¤ì¤â´Ö°ã¤¤¤Ç¤¹¡£

¤½¤Î¥×¥ê¥óÂÎÀݼè¤ÎÎ̤κ¹°Ê¾å¤Ë¡¢°û¼ò¤¬¤â¤¿¤é¤¹ÄËÉ÷ȯºî¤Î¥ê¥¹¥¯¤ÎÊý¤¬¡¢±Æ¶Á¤¬Â礭¤¤¤È¹Í¤¨¤é¤ì¤ë¤«¤é¤Ç¤¹4¡£¥Ó¥¸¥Í¥¹Àïά¤Ë¤Þ¤ó¤Þ¤È°ú¤Ã¤«¤«¤Ã¤Æ¤·¤Þ¤Ã¤Æ¤¤¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£

1¡¡Griebsch A, Zöllner N. Effect of ribomononucleotides given orally on uric acid production in man. Adv Exp Med Biol 1974; 41: 443-9.

2¡¡FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res ¡ÊHoboken¡Ë 2020; 72: 744-60.

3¡¡Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093-103.

4¡¡Neogi T, Chen C, Niu J, Chaisson C, Hunter DJ, Zhang Y. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med 2014; 127: 311-8.

»³ÅÄ Íª»Ë

ÊƹñϷǯ°å³Ø¡¦Æâ²ÊÀìÌç°å